US5869282A
(en)
*
|
1991-12-11 |
1999-02-09 |
Imperial Cancer Research Technology, Ltd. |
Nucleotide and protein sequences of the serrate gene and methods based thereon
|
US6004924A
(en)
|
1991-12-11 |
1999-12-21 |
Imperial Cancer Research Technology, Ltd. |
Protein sequences of serrate gene products
|
US5786158A
(en)
*
|
1992-04-30 |
1998-07-28 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
US20050112121A1
(en)
*
|
1992-04-30 |
2005-05-26 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
WO2000053753A2
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Promotion or inhibition of angiogenesis and cardiovascularization
|
PT861261E
(pt)
|
1995-06-28 |
2009-12-16 |
Imp Cancer Res Tech |
Sequências nucleotídicas e proteicas de genes delta de vertebrado e métodos nelas baseados
|
US5780300A
(en)
*
|
1995-09-29 |
1998-07-14 |
Yale University |
Manipulation of non-terminally differentiated cells using the notch pathway
|
JP4283891B2
(ja)
|
1995-11-17 |
2009-06-24 |
旭化成株式会社 |
分化抑制ポリペプチド
|
US6716974B1
(en)
*
|
1996-05-31 |
2004-04-06 |
Maine Medical Center Research Institute |
Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
|
AU720930B2
(en)
|
1996-07-16 |
2000-06-15 |
Asahi Kasei Kabushiki Kaisha |
Differentiation inhibitor
|
DE69733695T2
(de)
*
|
1996-11-07 |
2006-05-18 |
Lorantis Ltd. |
Notch-liganden zur verwendung in der immuntherapie
|
US6887475B1
(en)
|
1996-11-07 |
2005-05-03 |
Lorantis Limited |
Notch
|
US20060122373A1
(en)
|
1997-04-04 |
2006-06-08 |
Millennium Pharmaceuticals, Inc. |
Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof
|
US6121045A
(en)
*
|
1997-04-04 |
2000-09-19 |
Millennium Biotherapeutics, Inc. |
Human Delta3 nucleic acid molecules
|
ATE342358T1
(de)
*
|
1997-04-04 |
2006-11-15 |
Millennium Biotherapeutics Inc |
Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen
|
JP4171528B2
(ja)
|
1997-05-14 |
2008-10-22 |
旭化成株式会社 |
新規な分化抑制剤
|
AU737132B2
(en)
*
|
1997-06-18 |
2001-08-09 |
Zymogenetics Inc. |
Mammalian neuro-growth factor like protein
|
US6136952A
(en)
*
|
1997-06-25 |
2000-10-24 |
University Of Washington |
Human jagged polypeptide, encoding nucleic acids and methods of use
|
US6692919B1
(en)
|
1997-07-23 |
2004-02-17 |
Yale University |
Activated forms of notch and methods based thereon
|
US6436650B1
(en)
|
1997-07-23 |
2002-08-20 |
Yale University |
Activated forms of notch and methods based thereon
|
EP1518930B1
(de)
*
|
1998-10-13 |
2007-05-30 |
Genentech, Inc. |
Verfahren und Zusammenstzung zur Hemmung des Wachtums von neoplastischen Zellen
|
JP3695642B2
(ja)
*
|
1998-12-01 |
2005-09-14 |
ジェネンテック・インコーポレーテッド |
血管形成及び心臓血管新生の促進又は阻害
|
NZ512326A
(en)
*
|
1998-12-23 |
2003-11-28 |
Regeneron Pharma |
Fusion proteins containing at least two receptor binding domains and a multimer-forming component
|
US8084258B2
(en)
*
|
1999-07-12 |
2011-12-27 |
University Of Basel |
Manipulation of tissue of organ type using the notch pathway
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
AU2001280149A1
(en)
*
|
2000-08-25 |
2002-03-04 |
Asahi Kasei Kabushiki Kaisha |
Stem cell culture medium and culture method by using the same
|
AU2001288628A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Loyola University Chicago |
Method and reagents for treatment of skin disorders by modulating the notch pathway
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
IL156303A0
(en)
|
2000-12-06 |
2004-01-04 |
Robert J Hariri |
Method of collecting placental stem cells
|
US20080152629A1
(en)
*
|
2000-12-06 |
2008-06-26 |
James Edinger |
Placental stem cell populations
|
KR100973615B1
(ko)
*
|
2001-02-14 |
2010-08-02 |
안트로제네시스 코포레이션 |
산후 포유류의 태반, 이의 용도 및 태반 줄기세포
|
CA2856986C
(en)
|
2001-02-14 |
2019-08-13 |
Anthrogenesis Corporation |
Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
|
EP2292091A1
(de)
|
2002-02-13 |
2011-03-09 |
Anthrogenesis Corporation |
Embryoartige Stammzellen aus der Post Partum Plazenta von Säugetieren sowie Anwendungszwecke und Behandlungsverfahren, bei denen diese Zellen verwendet werden
|
US7498171B2
(en)
*
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
EP1525308A4
(de)
*
|
2002-05-30 |
2006-11-02 |
Celgene Corp |
Verfahren zur verwendung von jnk- oder mkk-inhibitoren zur modulation der zelldifferenzierung und zur behandlung von myeloproliferativen störungen und myelodysplastischen syndromen
|
BR0316695A
(pt)
|
2002-11-26 |
2005-10-18 |
Anthrogenesis Corp |
Unidade citoterapêutica, kit para tratamento, método de tratamento de uma enfermidade, biblioteca de unidades citoterapêuticas e método de tratamento de um paciente
|
JP2006517975A
(ja)
*
|
2003-02-13 |
2006-08-03 |
アンスロジェネシス コーポレーション |
疾患、障害または症状を患っている個体を治療するための臍帯血の使用
|
ITRM20030376A1
(it)
|
2003-07-31 |
2005-02-01 |
Univ Roma |
Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
|
US7795404B1
(en)
|
2003-08-08 |
2010-09-14 |
Five Prime Therapeutics, Inc. |
Human soluble notch receptor ligands
|
GB0321337D0
(en)
*
|
2003-09-11 |
2003-10-15 |
Massone Mobile Advertising Sys |
Method and system for distributing advertisements
|
NZ548049A
(en)
*
|
2003-12-02 |
2009-01-31 |
Celgene Corp |
Methods and compositions for the treatment and management of hemoglobinopathy and anemia
|
US11660317B2
(en)
|
2004-11-08 |
2023-05-30 |
The Johns Hopkins University |
Compositions comprising cardiosphere-derived cells for use in cell therapy
|
US7794742B2
(en)
*
|
2005-02-08 |
2010-09-14 |
University Of Washington |
Devices for promoting epithelial cell differentiation and keratinization
|
EP1957633B1
(de)
|
2005-10-13 |
2013-12-18 |
Anthrogenesis Corporation |
Immunmodulation unter verwendung von plazentastammzellen
|
HUE031122T2
(en)
|
2005-10-31 |
2017-07-28 |
Oncomed Pharm Inc |
Preparations and methods for the treatment of cancer based on human FZD receptors
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
CA2633775A1
(en)
|
2005-12-29 |
2007-07-12 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
ES2703502T3
(es)
|
2005-12-29 |
2019-03-11 |
Celularity Inc |
Poblaciones de células madre placentarias
|
WO2008121102A2
(en)
*
|
2006-02-21 |
2008-10-09 |
The Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
MX2008015645A
(es)
*
|
2006-06-09 |
2009-02-06 |
Anthrogenesis Corp |
Nicho placentario y uso de este para cultivar celulas primordiales.
|
PT2066694E
(pt)
|
2006-09-29 |
2016-01-27 |
Oncomed Pharm Inc |
Composições e métodos de diagnóstico e tratamento do cancro
|
RU2448979C2
(ru)
|
2006-12-14 |
2012-04-27 |
Ридженерон Фармасьютикалз, Инк. |
Антитела человека к дельта-подобному лиганду-4 человека
|
US8148147B2
(en)
|
2007-01-24 |
2012-04-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
RS52921B
(en)
*
|
2007-02-12 |
2014-02-28 |
Anthrogenesis Corporation |
TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL CELL CELLS
|
US20100172830A1
(en)
*
|
2007-03-29 |
2010-07-08 |
Cellx Inc. |
Extraembryonic Tissue cells and method of use thereof
|
US8802103B2
(en)
*
|
2007-05-15 |
2014-08-12 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
TWM322542U
(en)
*
|
2007-05-23 |
2007-11-21 |
Universal Scient Ind Co Ltd |
Testing machine
|
MX2010003217A
(es)
*
|
2007-09-26 |
2010-07-30 |
Celgene Cellular Therapeutics |
Celulas angiogenicas de perfundido de placenta humana.
|
KR20180107320A
(ko)
|
2007-09-28 |
2018-10-01 |
안트로제네시스 코포레이션 |
인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
|
KR20210056449A
(ko)
*
|
2007-11-07 |
2021-05-18 |
안트로제네시스 코포레이션 |
조산 합병증의 치료에 있어서의 제대혈의 용도
|
PE20110400A1
(es)
*
|
2008-08-20 |
2011-06-22 |
Anthrogenesis Corp |
Composiciones mejoradas de celulas y metodos para preparar las mismas
|
WO2010021715A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Anthrogenesis Corporation |
Treatment of stroke using isolated placental cells
|
JP2012500792A
(ja)
*
|
2008-08-22 |
2012-01-12 |
アンスロジェネシス コーポレーション |
胎盤細胞集団による骨欠損の治療のための方法および組成物
|
BRPI0919473A2
(pt)
|
2008-09-26 |
2017-08-29 |
Oncomed Pharm Inc |
Agentes de ligação frizzled e usos dos mesmos
|
NZ602455A
(en)
|
2008-11-19 |
2014-03-28 |
Anthrogenesis Corp |
Amnion derived adherent cells
|
EP2375907B1
(de)
*
|
2008-11-21 |
2019-02-27 |
Celularity, Inc. |
Behandlung von krankheiten, störungen oder leiden der lunge mittels plazentazellen
|
DK2488204T3
(en)
|
2009-10-16 |
2016-06-06 |
Oncomed Pharm Inc |
Therapeutic combination and use of DLL4 antagonist antibodies and blood pressure lowering agents
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
JP2013518108A
(ja)
*
|
2010-01-26 |
2013-05-20 |
アントフロゲネシス コーポレーション |
胎盤幹細胞を用いる骨関連癌の治療
|
MX347515B
(es)
|
2010-04-01 |
2017-04-28 |
Oncomed Pharmaceuticals Inc * |
Agentes que se unen al receptor encrespado y usos de los mismos.
|
TW201902496A
(zh)
|
2010-04-07 |
2019-01-16 |
美商安瑟吉納西斯公司 |
利用胎盤幹細胞之血管新生
|
CA2795401A1
(en)
|
2010-04-08 |
2011-10-13 |
Anthrogenesis Corporation |
Treatment of sarcoidosis using placental stem cells
|
US9249392B2
(en)
|
2010-04-30 |
2016-02-02 |
Cedars-Sinai Medical Center |
Methods and compositions for maintaining genomic stability in cultured stem cells
|
US9845457B2
(en)
|
2010-04-30 |
2017-12-19 |
Cedars-Sinai Medical Center |
Maintenance of genomic stability in cultured stem cells
|
EP3358007A1
(de)
|
2010-07-13 |
2018-08-08 |
Celularity, Inc. |
Verfahren zur erzeugung von natürlichen killerzellen
|
US8551479B2
(en)
|
2010-09-10 |
2013-10-08 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating melanoma
|
US9259443B2
(en)
|
2010-10-25 |
2016-02-16 |
The Children's Hospital Of Philadelphia |
Compositions and methods for the generation of platelets and methods of use thereof
|
AR084754A1
(es)
|
2010-12-30 |
2013-06-05 |
Anthrogenesis Corp |
Composiciones que comprenden celulas madre de placenta y plasma rico en plaquetas, y sus metodos de uso
|
AR084753A1
(es)
|
2010-12-30 |
2013-06-05 |
Anthrogenesis Corp |
Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp)
|
WO2012092485A1
(en)
|
2010-12-31 |
2012-07-05 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory rna molecules
|
WO2012166844A2
(en)
|
2011-06-01 |
2012-12-06 |
Anthrogenesis Corporation |
Treatment of pain using placental stem cells
|
US9925221B2
(en)
|
2011-09-09 |
2018-03-27 |
Celularity, Inc. |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
HRP20230078T1
(hr)
|
2011-09-23 |
2023-05-12 |
Mereo Biopharma 5, Inc. |
Sredstva za vezivanje vegf/dll4 i njihova uporaba
|
WO2013184527A1
(en)
|
2012-06-05 |
2013-12-12 |
Capricor, Inc. |
Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
|
EP2882445B1
(de)
|
2012-08-13 |
2019-04-24 |
Cedars-Sinai Medical Center |
Exosomen und mikroribonukleinsäuren zur geweberegeneration
|
CA2887711A1
(en)
|
2012-10-23 |
2014-05-01 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
US9599620B2
(en)
|
2012-10-31 |
2017-03-21 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a DLL4 antagonist
|
WO2014121196A1
(en)
|
2013-02-04 |
2014-08-07 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a wnt pathway inhibitor
|
AU2014215458A1
(en)
|
2013-02-05 |
2015-08-13 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
WO2016054591A1
(en)
|
2014-10-03 |
2016-04-07 |
Cedars-Sinai Medical Center |
Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
|
ES2808153T3
(es)
|
2014-10-31 |
2021-02-25 |
Mereo Biopharma 5 Inc |
Terapia de combinación para tratamiento de enfermedad
|
WO2017053705A1
(en)
|
2015-09-23 |
2017-03-30 |
Oncomed Pharmaceuticals, Inc. |
Methods and compositions for treatment of cancer
|
US11253551B2
(en)
|
2016-01-11 |
2022-02-22 |
Cedars-Sinai Medical Center |
Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
|
WO2017210652A1
(en)
|
2016-06-03 |
2017-12-07 |
Cedars-Sinai Medical Center |
Cdc-derived exosomes for treatment of ventricular tachyarrythmias
|
US11541078B2
(en)
|
2016-09-20 |
2023-01-03 |
Cedars-Sinai Medical Center |
Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
|
WO2018195210A1
(en)
|
2017-04-19 |
2018-10-25 |
Cedars-Sinai Medical Center |
Methods and compositions for treating skeletal muscular dystrophy
|
WO2019126068A1
(en)
|
2017-12-20 |
2019-06-27 |
Cedars-Sinai Medical Center |
Engineered extracellular vesicles for enhanced tissue delivery
|